Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Olatunji O. Adetokunboh, Anel Schoonees, Tolulope A. Balogun, Charles S. Wiysonge

ABSTRACT

BACKGROUND: Abacavir is one of the recommended nucleoside reverse transcriptase inhibitors (NRTIs) for the treatment of HIV infections among children and adolescents. However, there are concerns that the antiviral efficacy of abacavir might be low when compared to other NRTIs especially among children. There are also concerns that abacavir use may lead to serious adverse events such as hypersensitivity reactions and has potential predisposition to developing cardiovascular diseases METHODS: We searched four electronic databases, four conference proceedings and two clinical trial registries in August 2014, without language restrictions. Experimental and observational studies with control groups that examined the efficacy and safety of abacavir-containing regimens in comparison with other NRTIs as first-line treatment for HIV-infected children and adolescents aged between one month and eighteen years were eligible. Two authors independently screened search results, extracted data and assessed the risk of bias of included studies using a pre-specified, standardised data extraction form and validated risk of bias tools. We also assessed the quality of evidence per outcome with the GRADE tool. RESULTS: We included two randomised controlled trials (RCTs) and two analytical cohort studies with a total of 10,595 participants. Among the RCTs we detected no difference in virologic suppression after a mean duration of 48 weeks between abacavir- and stavudine-containing regimens (2 trials; n = 326: RR 1.28; 95 % CI 0.67-2.42) with significant heterogeneity (P = 0.02; I(2) = 81 %). We also found no significant differences between the two groups for adverse events and death. After five years of follow-up, virologic suppression improved with abacavir (1 trial; n = 69: RR 1.96; 95 % CI 1.11-3.44). For cohort studies, we detected that the virologic suppression activity of abacavir was less effective than stavudine in both the lopinavir/ritonavir (1 study, n = 2165: RR 0.79, 95 % CI 0.67-0.92) and efavirenz sub-groups (1 study, n = 3204: RR 0.79, 95 % CI 0.67-0.92) respectively. The quality of evidence from RCTs was moderate for virologic suppression but low for death and adverse events, while that of cohort studies was low for all three these outcomes. CONCLUSIONS: Available evidence showed little or no difference between abacavir-containing regimen and other NRTIs regarding efficacy and safety when given to children and adolescents as a first-line antiretroviral therapy. More... »

PAGES

469

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12879-015-1183-6

DOI

http://dx.doi.org/10.1186/s12879-015-1183-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035410558

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26502899


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-HIV Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiretroviral Therapy, Highly Active", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzoxazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dideoxynucleosides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lopinavir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ritonavir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stavudine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Stellenbosch University", 
          "id": "https://www.grid.ac/institutes/grid.11956.3a", 
          "name": [
            "Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa", 
            "Division of Community Health, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adetokunboh", 
        "givenName": "Olatunji O.", 
        "id": "sg:person.01001014230.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001014230.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stellenbosch University", 
          "id": "https://www.grid.ac/institutes/grid.11956.3a", 
          "name": [
            "Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schoonees", 
        "givenName": "Anel", 
        "id": "sg:person.01143720241.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143720241.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stellenbosch University", 
          "id": "https://www.grid.ac/institutes/grid.11956.3a", 
          "name": [
            "Division of Community Health, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Balogun", 
        "givenName": "Tolulope A.", 
        "id": "sg:person.0727373457.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727373457.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stellenbosch University", 
          "id": "https://www.grid.ac/institutes/grid.11956.3a", 
          "name": [
            "Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa", 
            "Division of Community Health, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wiysonge", 
        "givenName": "Charles S.", 
        "id": "sg:person.0667111132.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667111132.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1001/jama.285.15.2006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000259573"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32833f147f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001740056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32833f147f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001740056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32833f147f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001740056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32833f147f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001740056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e328347fa16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002977429"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e328347fa16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002977429"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0000000000000308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005178106"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0000000000000308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005178106"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd005481.pub3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008893450"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-3156.2010.02688.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009743543"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e3280e087e7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011084479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e3280e087e7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011084479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(02)07874-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016764086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31828e8c09", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016864015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31828e8c09", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016864015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31828e8c09", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016864015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31828c3738", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018565944"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e31828c3738", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018565944"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd008270.pub2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022309442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32830fe35e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028063841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e32830fe35e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028063841"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-1293.2006.00381.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028508348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199816000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030752705"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002030-199816000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030752705"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(10)70313-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031433558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.107.1.e4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032489218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-1293.2009.00724.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032639299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(08)60423-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034632701"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2046-4053-3-87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036354122", 
          "https://doi.org/10.1186/2046-4053-3-87"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e3182076864", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036363580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0b013e3182076864", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036363580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jac/dku279", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036624012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/339751", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037290372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e328349c6ee", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039909162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qad.0b013e328349c6ee", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039909162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qai.0b013e31826f993c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040148173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/qai.0b013e31826f993c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040148173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1k522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041231119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1k522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041231119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0149-2918(02)80057-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048489357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0149-2918(02)80057-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048489357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0000000000000222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049980441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/inf.0000000000000222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049980441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2535", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2535", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.103.4.e47", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067819930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3851/imp2695", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071479821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078841315", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/aac.41.5.1082", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083087386"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: Abacavir is one of the recommended nucleoside reverse transcriptase inhibitors (NRTIs) for the treatment of HIV infections among children and adolescents. However, there are concerns that the antiviral efficacy of abacavir might be low when compared to other NRTIs especially among children. There are also concerns that abacavir use may lead to serious adverse events such as hypersensitivity reactions and has potential predisposition to developing cardiovascular diseases\nMETHODS: We searched four electronic databases, four conference proceedings and two clinical trial registries in August 2014, without language restrictions. Experimental and observational studies with control groups that examined the efficacy and safety of abacavir-containing regimens in comparison with other NRTIs as first-line treatment for HIV-infected children and adolescents aged between one month and eighteen years were eligible. Two authors independently screened search results, extracted data and assessed the risk of bias of included studies using a pre-specified, standardised data extraction form and validated risk of bias tools. We also assessed the quality of evidence per outcome with the GRADE tool.\nRESULTS: We included two randomised controlled trials (RCTs) and two analytical cohort studies with a total of 10,595 participants. Among the RCTs we detected no difference in virologic suppression after a mean duration of 48 weeks between abacavir- and stavudine-containing regimens (2 trials; n = 326: RR 1.28; 95 % CI 0.67-2.42) with significant heterogeneity (P = 0.02; I(2) = 81 %). We also found no significant differences between the two groups for adverse events and death. After five years of follow-up, virologic suppression improved with abacavir (1 trial; n = 69: RR 1.96; 95 % CI 1.11-3.44). For cohort studies, we detected that the virologic suppression activity of abacavir was less effective than stavudine in both the lopinavir/ritonavir (1 study, n = 2165: RR 0.79, 95 % CI 0.67-0.92) and efavirenz sub-groups (1 study, n = 3204: RR 0.79, 95 % CI 0.67-0.92) respectively. The quality of evidence from RCTs was moderate for virologic suppression but low for death and adverse events, while that of cohort studies was low for all three these outcomes.\nCONCLUSIONS: Available evidence showed little or no difference between abacavir-containing regimen and other NRTIs regarding efficacy and safety when given to children and adolescents as a first-line antiretroviral therapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12879-015-1183-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "name": "Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis", 
    "pagination": "469", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a8ae01f24888b7dd1f33e940030c9957e3bddecc5e93555ea006cc79c673a242"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26502899"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968551"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12879-015-1183-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035410558"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12879-015-1183-6", 
      "https://app.dimensions.ai/details/publication/pub.1035410558"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000514.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12879-015-1183-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12879-015-1183-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12879-015-1183-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12879-015-1183-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12879-015-1183-6'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      78 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12879-015-1183-6 schema:about N107652429b9e411db2f0ef50672aacc1
2 N15e8e3c489d44c70ab8d6f2f42fe1c46
3 N1a1fac696e8a488f9316f3a675991015
4 N1badf1b4b44042bc8db0e4905518bb0c
5 N1fa8853794d44ba692b15df8e7d89b05
6 N20eac8de719e43118cdf8197990d553d
7 N4a947e2af06e429bb5aa94a3497d20fa
8 N500fdd4545ef498dab8a21a6e74cc782
9 N86437605b6e7450bb400a5e24906e98b
10 Naeda33bc48bc4e25b31d14fa04c8611b
11 Nc3f4cdad8b8647bf863268926612e589
12 Ncfdff62afebc432e8ed0fdc142a30621
13 Ne24c9e028d14481d912a49056b19211a
14 Ne8ec8ab761a54c519488d723104f66c7
15 Nf0112b70ecbe4b2da80b5daabd1e40f2
16 Nf0cc2a6003dd4eef99f24f6db68deaed
17 Nffdc4437559c4ba2bd98c982a0567f79
18 anzsrc-for:11
19 anzsrc-for:1117
20 schema:author N60ca272a2c354af2b292d7fd32b11e76
21 schema:citation sg:pub.10.1186/2046-4053-3-87
22 https://app.dimensions.ai/details/publication/pub.1078841315
23 https://doi.org/10.1001/jama.285.15.2006
24 https://doi.org/10.1002/14651858.cd005481.pub3
25 https://doi.org/10.1002/14651858.cd008270.pub2
26 https://doi.org/10.1016/s0140-6736(02)07874-1
27 https://doi.org/10.1016/s0140-6736(08)60423-7
28 https://doi.org/10.1016/s0149-2918(02)80057-1
29 https://doi.org/10.1016/s1473-3099(10)70313-3
30 https://doi.org/10.1086/339751
31 https://doi.org/10.1093/jac/dku279
32 https://doi.org/10.1097/00002030-199816000-00002
33 https://doi.org/10.1097/inf.0000000000000222
34 https://doi.org/10.1097/inf.0000000000000308
35 https://doi.org/10.1097/inf.0b013e3182076864
36 https://doi.org/10.1097/inf.0b013e31828c3738
37 https://doi.org/10.1097/inf.0b013e31828e8c09
38 https://doi.org/10.1097/qad.0b013e3280e087e7
39 https://doi.org/10.1097/qad.0b013e32830fe35e
40 https://doi.org/10.1097/qad.0b013e32833f147f
41 https://doi.org/10.1097/qad.0b013e328347fa16
42 https://doi.org/10.1097/qad.0b013e328349c6ee
43 https://doi.org/10.1097/qai.0b013e31826f993c
44 https://doi.org/10.1111/j.1365-3156.2010.02688.x
45 https://doi.org/10.1111/j.1468-1293.2006.00381.x
46 https://doi.org/10.1111/j.1468-1293.2009.00724.x
47 https://doi.org/10.1128/aac.41.5.1082
48 https://doi.org/10.1136/bmj.b2535
49 https://doi.org/10.1345/aph.1k522
50 https://doi.org/10.1542/peds.103.4.e47
51 https://doi.org/10.1542/peds.107.1.e4
52 https://doi.org/10.3851/imp2695
53 schema:datePublished 2015-12
54 schema:datePublishedReg 2015-12-01
55 schema:description BACKGROUND: Abacavir is one of the recommended nucleoside reverse transcriptase inhibitors (NRTIs) for the treatment of HIV infections among children and adolescents. However, there are concerns that the antiviral efficacy of abacavir might be low when compared to other NRTIs especially among children. There are also concerns that abacavir use may lead to serious adverse events such as hypersensitivity reactions and has potential predisposition to developing cardiovascular diseases METHODS: We searched four electronic databases, four conference proceedings and two clinical trial registries in August 2014, without language restrictions. Experimental and observational studies with control groups that examined the efficacy and safety of abacavir-containing regimens in comparison with other NRTIs as first-line treatment for HIV-infected children and adolescents aged between one month and eighteen years were eligible. Two authors independently screened search results, extracted data and assessed the risk of bias of included studies using a pre-specified, standardised data extraction form and validated risk of bias tools. We also assessed the quality of evidence per outcome with the GRADE tool. RESULTS: We included two randomised controlled trials (RCTs) and two analytical cohort studies with a total of 10,595 participants. Among the RCTs we detected no difference in virologic suppression after a mean duration of 48 weeks between abacavir- and stavudine-containing regimens (2 trials; n = 326: RR 1.28; 95 % CI 0.67-2.42) with significant heterogeneity (P = 0.02; I(2) = 81 %). We also found no significant differences between the two groups for adverse events and death. After five years of follow-up, virologic suppression improved with abacavir (1 trial; n = 69: RR 1.96; 95 % CI 1.11-3.44). For cohort studies, we detected that the virologic suppression activity of abacavir was less effective than stavudine in both the lopinavir/ritonavir (1 study, n = 2165: RR 0.79, 95 % CI 0.67-0.92) and efavirenz sub-groups (1 study, n = 3204: RR 0.79, 95 % CI 0.67-0.92) respectively. The quality of evidence from RCTs was moderate for virologic suppression but low for death and adverse events, while that of cohort studies was low for all three these outcomes. CONCLUSIONS: Available evidence showed little or no difference between abacavir-containing regimen and other NRTIs regarding efficacy and safety when given to children and adolescents as a first-line antiretroviral therapy.
56 schema:genre research_article
57 schema:inLanguage en
58 schema:isAccessibleForFree true
59 schema:isPartOf N454c205aa4de457183766d28079ad622
60 Nba4ebe3264314a53985eb374b0216122
61 sg:journal.1024946
62 schema:name Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis
63 schema:pagination 469
64 schema:productId N0324c15d2bb2484babc46946db6cbe4e
65 N533d69228005447c9dfa779fd77a3053
66 N992e93e8015e49ac81424babedb986ae
67 Nda564e00f034480f9c91f91e604189e3
68 Nfa8383e6b1a449efbba14d49f8e5d61d
69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035410558
70 https://doi.org/10.1186/s12879-015-1183-6
71 schema:sdDatePublished 2019-04-11T02:01
72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
73 schema:sdPublisher Nec1441f7c3884443b43e53853d72fadb
74 schema:url http://link.springer.com/10.1186%2Fs12879-015-1183-6
75 sgo:license sg:explorer/license/
76 sgo:sdDataset articles
77 rdf:type schema:ScholarlyArticle
78 N0324c15d2bb2484babc46946db6cbe4e schema:name dimensions_id
79 schema:value pub.1035410558
80 rdf:type schema:PropertyValue
81 N107652429b9e411db2f0ef50672aacc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Humans
83 rdf:type schema:DefinedTerm
84 N15e8e3c489d44c70ab8d6f2f42fe1c46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Infant
86 rdf:type schema:DefinedTerm
87 N1a1fac696e8a488f9316f3a675991015 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Child
89 rdf:type schema:DefinedTerm
90 N1badf1b4b44042bc8db0e4905518bb0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Benzoxazines
92 rdf:type schema:DefinedTerm
93 N1fa8853794d44ba692b15df8e7d89b05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Anti-HIV Agents
95 rdf:type schema:DefinedTerm
96 N20eac8de719e43118cdf8197990d553d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Male
98 rdf:type schema:DefinedTerm
99 N3de8a2c3a1eb4fd29c5c546213887fa9 rdf:first sg:person.01143720241.43
100 rdf:rest Ncb52b317f1c149e393c250bcaa7cd60f
101 N454c205aa4de457183766d28079ad622 schema:volumeNumber 15
102 rdf:type schema:PublicationVolume
103 N4a947e2af06e429bb5aa94a3497d20fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antiretroviral Therapy, Highly Active
105 rdf:type schema:DefinedTerm
106 N500fdd4545ef498dab8a21a6e74cc782 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Dideoxynucleosides
108 rdf:type schema:DefinedTerm
109 N533d69228005447c9dfa779fd77a3053 schema:name doi
110 schema:value 10.1186/s12879-015-1183-6
111 rdf:type schema:PropertyValue
112 N60ca272a2c354af2b292d7fd32b11e76 rdf:first sg:person.01001014230.37
113 rdf:rest N3de8a2c3a1eb4fd29c5c546213887fa9
114 N86437605b6e7450bb400a5e24906e98b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Stavudine
116 rdf:type schema:DefinedTerm
117 N9226ee41420d498bbf4596fb440e9731 rdf:first sg:person.0667111132.59
118 rdf:rest rdf:nil
119 N992e93e8015e49ac81424babedb986ae schema:name readcube_id
120 schema:value a8ae01f24888b7dd1f33e940030c9957e3bddecc5e93555ea006cc79c673a242
121 rdf:type schema:PropertyValue
122 Naeda33bc48bc4e25b31d14fa04c8611b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Cohort Studies
124 rdf:type schema:DefinedTerm
125 Nba4ebe3264314a53985eb374b0216122 schema:issueNumber 1
126 rdf:type schema:PublicationIssue
127 Nc3f4cdad8b8647bf863268926612e589 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Adolescent
129 rdf:type schema:DefinedTerm
130 Ncb52b317f1c149e393c250bcaa7cd60f rdf:first sg:person.0727373457.76
131 rdf:rest N9226ee41420d498bbf4596fb440e9731
132 Ncfdff62afebc432e8ed0fdc142a30621 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Ritonavir
134 rdf:type schema:DefinedTerm
135 Nda564e00f034480f9c91f91e604189e3 schema:name nlm_unique_id
136 schema:value 100968551
137 rdf:type schema:PropertyValue
138 Ne24c9e028d14481d912a49056b19211a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Drug Therapy, Combination
140 rdf:type schema:DefinedTerm
141 Ne8ec8ab761a54c519488d723104f66c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name HIV Infections
143 rdf:type schema:DefinedTerm
144 Nec1441f7c3884443b43e53853d72fadb schema:name Springer Nature - SN SciGraph project
145 rdf:type schema:Organization
146 Nf0112b70ecbe4b2da80b5daabd1e40f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 Nf0cc2a6003dd4eef99f24f6db68deaed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Lopinavir
151 rdf:type schema:DefinedTerm
152 Nfa8383e6b1a449efbba14d49f8e5d61d schema:name pubmed_id
153 schema:value 26502899
154 rdf:type schema:PropertyValue
155 Nffdc4437559c4ba2bd98c982a0567f79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Child, Preschool
157 rdf:type schema:DefinedTerm
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
162 schema:name Public Health and Health Services
163 rdf:type schema:DefinedTerm
164 sg:journal.1024946 schema:issn 1471-2334
165 schema:name BMC Infectious Diseases
166 rdf:type schema:Periodical
167 sg:person.01001014230.37 schema:affiliation https://www.grid.ac/institutes/grid.11956.3a
168 schema:familyName Adetokunboh
169 schema:givenName Olatunji O.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001014230.37
171 rdf:type schema:Person
172 sg:person.01143720241.43 schema:affiliation https://www.grid.ac/institutes/grid.11956.3a
173 schema:familyName Schoonees
174 schema:givenName Anel
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143720241.43
176 rdf:type schema:Person
177 sg:person.0667111132.59 schema:affiliation https://www.grid.ac/institutes/grid.11956.3a
178 schema:familyName Wiysonge
179 schema:givenName Charles S.
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667111132.59
181 rdf:type schema:Person
182 sg:person.0727373457.76 schema:affiliation https://www.grid.ac/institutes/grid.11956.3a
183 schema:familyName Balogun
184 schema:givenName Tolulope A.
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727373457.76
186 rdf:type schema:Person
187 sg:pub.10.1186/2046-4053-3-87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036354122
188 https://doi.org/10.1186/2046-4053-3-87
189 rdf:type schema:CreativeWork
190 https://app.dimensions.ai/details/publication/pub.1078841315 schema:CreativeWork
191 https://doi.org/10.1001/jama.285.15.2006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000259573
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1002/14651858.cd005481.pub3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008893450
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1002/14651858.cd008270.pub2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022309442
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/s0140-6736(02)07874-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016764086
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/s0140-6736(08)60423-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034632701
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/s0149-2918(02)80057-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048489357
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/s1473-3099(10)70313-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031433558
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1086/339751 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037290372
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1093/jac/dku279 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036624012
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1097/00002030-199816000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030752705
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1097/inf.0000000000000222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049980441
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1097/inf.0000000000000308 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005178106
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1097/inf.0b013e3182076864 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036363580
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1097/inf.0b013e31828c3738 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018565944
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1097/inf.0b013e31828e8c09 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016864015
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1097/qad.0b013e3280e087e7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011084479
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1097/qad.0b013e32830fe35e schema:sameAs https://app.dimensions.ai/details/publication/pub.1028063841
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1097/qad.0b013e32833f147f schema:sameAs https://app.dimensions.ai/details/publication/pub.1001740056
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1097/qad.0b013e328347fa16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002977429
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1097/qad.0b013e328349c6ee schema:sameAs https://app.dimensions.ai/details/publication/pub.1039909162
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1097/qai.0b013e31826f993c schema:sameAs https://app.dimensions.ai/details/publication/pub.1040148173
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1111/j.1365-3156.2010.02688.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009743543
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1111/j.1468-1293.2006.00381.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028508348
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1111/j.1468-1293.2009.00724.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032639299
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1128/aac.41.5.1082 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083087386
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1136/bmj.b2535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062802292
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1345/aph.1k522 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041231119
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1542/peds.103.4.e47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067819930
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1542/peds.107.1.e4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032489218
248 rdf:type schema:CreativeWork
249 https://doi.org/10.3851/imp2695 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071479821
250 rdf:type schema:CreativeWork
251 https://www.grid.ac/institutes/grid.11956.3a schema:alternateName Stellenbosch University
252 schema:name Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa
253 Division of Community Health, Faculty of Medicine and Health Sciences, Stellenbosch University, 7505, Cape Town, South Africa
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...